Author

Mirvald C

Fundeni Clinical Institute, Department of Urology - Cited by 304 - Urology

Biography

Christian Miravald is an Urologist working at Fundeni Clinical Institute, Department of Urology is from Carol Davila” University of General Medicine and Pharmacya at Bucharest, Romania and Fundeni Clinical Institute, Department of Uronephrology and Renal Transplant, Bucharest, Romania.
Title
Cited by
Year
Can we expand active surveillance criteria to include biopsy Gleason 3+ 4 prostate cancer? A multi-institutional study of 2,323 patients
G Ploussard, H Isbarn, A Briganti, P Sooriakumaran, CI Surcel, L Salomon, ...Urologic Oncology: Seminars and Original Investigations 33 (2), 71. e1-71. e9, 2015201
83
2015
Management of idiopathic retroperitoneal fibrosis from the urologist’s perspective
C Surcel, C Mirvald, C Pavelescu, C Gingu, S Carmen, H Emre, S IoanelTherapeutic advances in urology 7 (2), 85-99, 2015201
49
2015
Outcome of papillary versus clear cell renal cell carcinoma varies significantly in non-metastatic disease
N Wagener, D Edelmann, A Benner, R Zigeuner, H Borgmann, I Wolff, ...Plos one 12 (9), e0184173, 2017201
33
2017
Aggressive variants of prostate cancer–are we ready to apply specific treatment right now?
I Tsaur, I Heidegger, A Kretschmer, H Borgmann, G Gandaglia, A Briganti, ...Cancer treatment reviews 75, 20-26, 2019201
25
2019
Prognostic significance of Fuhrman grade and age for cancer-specific and overall survival in patients with papillary renal cell carcinoma: results of an international multi …
H Borgmann, M Musquera, A Haferkamp, A Vilaseca, T Klatte, SF Shariat, ...World journal of urology 35, 1891-1897, 2017201
25
2017
Members of the Prostate Cancer Working Group of the Young Academic Urologists Working Party of the European Association of U. Can we expand active surveillance criteria to …
G Ploussard, H Isbarn, A Briganti, P Sooriakumaran, CI Surcel, L Salomon, ...Urol Oncol 33 (71), e71-79, 20120
5
2015
Neuroendocrine syndrome in bronchial carcinoid tumors
C Savu, A Melinte, JL Lukadi, C Mirvald, C Savu, E Belu, C Diaconu, ...Experimental and Therapeutic Medicine 20 (6), 1-1, 2020202
5
2020
Prognostic and discriminative power of the 7th TNM classification for patients with surgically treated papillary renal cell carcinoma: results of a multi-institutional …
M May, C Surcel, U Capitanio, P Dell’Oglio, T Klatte, S Shariat, T Ecke, ...Scandinavian journal of urology 1 (4), 269-276, 2017201
5
2017
External validation of a postoperative nomogram for the prediction of disease-specific survival in patients with papillary renal cell carcinoma using a large multicenter database
S Zastrow, LM Krabbe, I Wolff, U Capitanio, T Klatte, T Ecke, N Huck, ...International Journal of Clinical Oncology 25, 15-150, 2020202
4
2020
Contemporary role of palliative cystoprostatectomy or pelvic exenteration in advanced symptomatic prostate cancer
C Surcel, C Mirvald, I Tsaur, H Borgmann, I Heidegger, AP Labanaris, ...World journal of urology 9, 248-2490, 2021202
3
2021
Surgical management of urachal tumors: Can the umbilicus be sparred in localized disease?
C Pavelescu, A Pavelescu, C Surcel, C Mirvald, M Alvarez-Maestro, ...Rare Tumors 11, 206611984728, 2019201
3
2019
Medical management in locally advanced and metastatic prostate cancer: Does changes in treatment policy have any specific effect on PSA levels?
M Bagcioglu, C Surcel, S Ozcan, C Mirvald, MA Karagoz, MA Karadag, ...Archivio Italiano di Urologia e Andrologia 89 (4), 8-86, 01701
2
2017
C134: Early complication rates and perioperative mortality after radical cystectomy in the elderly
C Mirvald, C Surcel, C Gingu, C Pavelescu, V Cerempei, S Najjar, V Olaru, ...European Urology Supplements 6 (13), e1319, 01401
2
2014
Organ preservation is less frequently performed in women surgically treated for papillary renal cell carcinoma—results of a comprehensive multicenter study
I Wolff, A Scavuzzo, U Capitanio, T Klatte, SF Shariat, N Wagener, ...Urology 109, 107-114, 01701
2
2017
Focal therapy for primary tumor and metastases in de novo or recurrent oligometastatic prostate cancer: current standing and future perspectives
I Tsaur, RA Blaheta, R Dotzauer, MP Brandt, G Gandaglia, I Sinescu, ...World Journal of Urology, -4, 2022202
1
2022
Combining anticancer drugs with osteoprotective agents in prostate cancer—A contemporary update
I Tsaur, I Heidegger, A Kretschmer, H Borgmann, C Mirvald, G Gandaglia, ...Urologic Oncology: Seminars and Original Investigations 36 (), 488-497, 20820
1
2018
Molecular Mechanisms Related with Oligometastatic Prostate Cancer—Is It Just a Matter of Numbers?
C Surcel, A Kretschmer, C Mirvald, I Sinescu, I Heidegger, I TsaurCancers 4 (3), 766, 2022202
1
2022
Neutrophil-lymphocyte ratio and platelet-lymphocyte ratio vs. Fournier Gangrene severity index as prognostic factors in management of Fournier Gangrene
MA Manu, B Parliteanu, I Prie, C Dudu, C Surcel, B Stefan, R Manu, ...European Urology Supplements 6 (4), e7, 20520
1
2015
Challenges in Diagnosis of Uretero–Arterial Fistulas after Complex Pelvic Oncological Procedures—Single Center Experience and Review of the Literature
C Surcel, C Mirvald, R Stoica, V Cerempei, I Heidegger, A Labanaris, ...Diagnostics 2 (8), 832, 2022202
1
2022

Referred From: https://scholar.google.com/citations?user=EVMB-GQAAAAJ&hl=en&oi=ao

Cited by
Citations 304
h-index 7
i10-index 7
Open Access Journals